Joost J Oppenheim

5PUBLICATIONS
10CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cheminformatics and quantitative structure-activity relationshipsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 01, 2020
Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4+Foxp3+ regulatory T cells.

Tianzhen He, De Yang, Xiao-Qing Li

|Jun 05, 2019
Inhibition of murine hepatoma tumor growth by cryptotanshinone involves TLR7-dependent activation of macrophages and induction of adaptive antitumor immune defenses.

Zhen Han, Shuo Liu, Hongsheng Lin

|Apr 12, 2019
Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma.

Shuo Liu, Zhen Han, Anna L Trivett

|Jan 04, 2018
Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer.

Yingjie Nie, Jiang He, Hidekazu Shirota

|Oct 14, 2017
Alarmins and immunity.

De Yang, Zhen Han, Joost J Oppenheim

Pageof 1

Frequent Collaborators

2 joint publications

Anna L Trivett

2 joint publications

De Yang

2 joint publications

Xin Chen

1 joint publications

Yingjie Nie